PhytoPyo is the result of several years of research carried out by the French company Alphanosos, a pioneer in the application of artificial intelligence to natural medicine. The approach is based on a founding idea: to exploit the therapeutic potential of edible plants through a rigorous, scientific, and iterative approach, in order to discover natural, effective, and sustainable solutions.
At the heart of this approach is a unique artificial intelligence, capable of exploring more than 10⁴⁸ possible combinations of edible plant extracts. HAS At each iteration, the experimental results feed into an evolving model, which refines its predictions until optimal synergy is achieved. This method has enabled the creation of targeted formulations that are both innovative and scientifically validated.
It is in this context that PhytoPyo was born, a 100% natural lotion dedicated to the treatment of canine pyoderma of bacterial origin. Formulated with carefully selected edible plants, it soothes the skin, promotes healing, and reduces itching, without the use of antibiotics or corticosteroids. Its effectiveness has been confirmed by veterinary clinical studies, demonstrating a significant reduction in symptoms from the first days of use.
This work is led by Professor Pascal Mayer, co-founder and scientific director of Alphanosos. Internationally recognized for his contributions to biotechnology, Professor Mayer was a finalist for the European Inventor Award in 2020 for his work on ultra-fast DNA sequencing. Today, he puts his expertise to work in the service of natural solutions that respect living organisms and the microbiota, in fields as varied as dermatology, oncology, infectious diseases and the fight against invasive species.
PhytoPyo, at the crossroads of technology, plant science and animal well-being, embodies this ambitious vision: to bring about a new generation of effective, natural and responsible care, thanks to the power of artificial intelligence.